Bayer reports positive data from Phase III ARAMIS trial
Bayer has reported positive results from its Phase III ARAMIS trial after it met the primary endpoint.
ARAMIS Bayer darolutamide
Bayer has reported positive results from its Phase III ARAMIS trial after it met the primary endpoint.